Sabra Healthcare REIT (NASDAQ:SBRA) Stock Rating Lowered by Wall Street Zen

Sabra Healthcare REIT (NASDAQ:SBRA) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

SBRA has been the topic of a number of other reports. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. UBS Group initiated coverage on Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective for the company. Cantor Fitzgerald started coverage on Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 target price on the stock. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of “Hold” and a consensus target price of $21.11.

Sabra Healthcare REIT Stock Down 1.1%

Shares of Sabra Healthcare REIT stock opened at $18.82 on Friday. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19. The stock has a market cap of $4.69 billion, a price-to-earnings ratio of 26.14, a PEG ratio of 1.32 and a beta of 0.67. The firm’s 50-day moving average is $19.05 and its two-hundred day moving average is $18.70. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.01. The firm had revenue of $190.04 million during the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, research analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Founders Capital Management acquired a new stake in shares of Sabra Healthcare REIT during the 3rd quarter worth approximately $28,000. Danske Bank A S purchased a new stake in Sabra Healthcare REIT during the third quarter worth $30,000. Larson Financial Group LLC grew its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the period. Covestor Ltd increased its holdings in Sabra Healthcare REIT by 23,720.0% in the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 1,536 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.